ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,506, issued on May 6, was assigned to DermBiont Inc. (Boston).

"Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders" was invented by Emma Taylor (San Francisco), Karl Beutner (Fairfield, Calif.), Christopher Phillips (Doylestown, Pa.), Mark De Souza (Berkeley, Calif.), Ravi Kumar Pandrapragada (Clarksburg, Md.), Vanessa Alexandra Cofre Urrutia (Santiago, Chile), Brendan Philip Brady (Guildford, Great Britain) and Charles Rodney Greenaway Evans (Godalming, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprisi...